204 related articles for article (PubMed ID: 11880419)
1. Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals.
Heegaard ED; Petersen BL; Heilmann CJ; Hornsleth A
J Clin Microbiol; 2002 Mar; 40(3):933-6. PubMed ID: 11880419
[TBL] [Abstract][Full Text] [Related]
2. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
3. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum.
Erdman DD; Usher MJ; Tsou C; Caul EO; Gary GW; Kajigaya S; Young NS; Anderson LJ
J Med Virol; 1991 Oct; 35(2):110-5. PubMed ID: 1765775
[TBL] [Abstract][Full Text] [Related]
4. Parvovirus B19 and parvovirus V9 are not associated with Henoch-Schönlein purpura in children.
Heegaard ED; Taaning EB
Pediatr Infect Dis J; 2002 Jan; 21(1):31-4. PubMed ID: 11791095
[TBL] [Abstract][Full Text] [Related]
5. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin.
Cassinotti P; Siegl G; Michel BA; Brühlmann P
J Med Virol; 1998 Nov; 56(3):199-204. PubMed ID: 9783685
[TBL] [Abstract][Full Text] [Related]
6. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy.
Söderlund M; von Essen R; Haapasaari J; Kiistala U; Kiviluoto O; Hedman K
Lancet; 1997 Apr; 349(9058):1063-5. PubMed ID: 9107245
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders.
Lundqvist A; Tolfvenstam T; Brytting M; Stolt CM; Hedman K; Broliden K
Scand J Infect Dis; 1999; 31(2):119-22. PubMed ID: 10447317
[TBL] [Abstract][Full Text] [Related]
8. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
Cassinotti P; Burtonboy G; Fopp M; Siegl G
J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
[TBL] [Abstract][Full Text] [Related]
9. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
Lehmann HW; Knöll A; Küster RM; Modrow S
Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
[TBL] [Abstract][Full Text] [Related]
10. Detection of human parvovirus B19 infection: a study of 212 suspected cases in the state of Rio de Janeiro, Brazil.
Wermelinger MC; Oelemann WM; Lima de Mendonça MC; Naveca FG; von Hubinger MG
J Clin Virol; 2002 Aug; 25(2):223-30. PubMed ID: 12367658
[TBL] [Abstract][Full Text] [Related]
11. Low prevalence of active parvovirus B19 infection in HIV-infected patients.
Raguin G; Leruez-Ville M; Gregoire V; Deplanche M; Leport C; Morinet F; Vilde JL
Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):760-2. PubMed ID: 9405950
[TBL] [Abstract][Full Text] [Related]
12. Human parvovirus B19: immunity of Greek females and prenatal investigation of hydrops fetalis.
Kyriazopoulou V; Simitsopoulou M; Bondis J; Diza E; Athanasiadis A; Frantzidou F; Souliou E
Eur J Obstet Gynecol Reprod Biol; 1997 Aug; 74(2):157-60. PubMed ID: 9306109
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
Braham S; Gandhi J; Beard S; Cohen B
J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
[TBL] [Abstract][Full Text] [Related]
14. Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique.
Török TJ; Wang QY; Gary GW; Yang CF; Finch TM; Anderson LJ
Clin Infect Dis; 1992 Jan; 14(1):149-55. PubMed ID: 1571420
[TBL] [Abstract][Full Text] [Related]
15. Parvovirus B19 infection of bone marrow in systemic sclerosis patients.
Ferri C; Zakrzewska K; Longombardo G; Giuggioli D; Storino FA; Pasero G; Azzi A
Clin Exp Rheumatol; 1999; 17(6):718-20. PubMed ID: 10609071
[TBL] [Abstract][Full Text] [Related]
16. Evidence for persistence of parvovirus B19 DNA in livers of adults.
Eis-Hübinger AM; Reber U; Abdul-Nour T; Glatzel U; Lauschke H; Pütz U
J Med Virol; 2001 Oct; 65(2):395-401. PubMed ID: 11536250
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow.
Lundqvist A; Tolfvenstam T; Bostic J; Söderlund M; Broliden K
Scand J Infect Dis; 1999; 31(1):11-6. PubMed ID: 10381211
[TBL] [Abstract][Full Text] [Related]
18. Relevance of specific immunoglobulin M and immunoglobulin G for parvovirus B19 diagnosis in patients with acute lymphoblastic leukemia receiving chemotherapy: prospective study.
el-Sayed Zaki M
Arch Pathol Lab Med; 2007 Nov; 131(11):1697-9. PubMed ID: 17979489
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of parvovirus B19-specific antibodies and of viral DNA in patients with endogenous uveitis.
Heinz C; Plentz A; Bauer D; Heiligenhaus A; Modrow S
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):999-1004. PubMed ID: 15906067
[TBL] [Abstract][Full Text] [Related]
20. Parvovirus B19 quiescence during the course of human immunodeficiency virus infection in persons with hemophilia.
Goedert JJ; Erdman DD; Konkle BA; Török TJ; Lederman MM; Kleinert D; Mandalaki T; Kessler CM; Anderson LJ; Luban NL
Am J Hematol; 1997 Dec; 56(4):248-51. PubMed ID: 9395187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
